Literature DB >> 12861493

[How are interstitial lung diseases diagnosed in Germany? Results of the scientific registry for the exploration of interstitial lung diseases ("Fibrosis registry") of the WATL].

H Schweisfurth1, C Kieslich, N Satake, R Loddenkemper, N Schönfeld, I Mäder, D Treutler, W Matthiessen, C Schmidt, P Leonhardt, G Siemon, N deWall, U Gereke, U Costabel.   

Abstract

From 1995 to 1999 we evaluated questionnaires sent by pulmonologists and departments of pulmonology in order to register interstitial lung diseases. On the whole 1142 patients (579 males, 563 females, mean age 51.1 +/- 15.3 years, sarcoidosis, n = 511, extrinsic allergic alveolitis, n = 145, idiopathic pulmonary fibrosis, n = 308, bronchiolitis obliterans organizing pneumonia (BOOP), n = 93, others, n = 85) were recorded in the registry. With reference to the mean age sarcoidosis occurred most frequently in the fourth decade and idiopathic pulmonary fibrosis in the sixth decade. In all these diseases bronchoscopy with bronchoalveolar lavage and transbronchial biopsy was predominantly used for further diagnosis. It was striking that high-resolution computed tomography of the thorax was still rarely used when diagnosing these diseases. Apart from the group with BOOP the number of non-smokers in men and women was decisively higher than the average of the population of Germany.

Entities:  

Mesh:

Year:  2003        PMID: 12861493     DOI: 10.1055/s-2003-40557

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  6 in total

1.  [Pulmonary fibrosis].

Authors:  A Prasse; J U Holle; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

2.  Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.

Authors:  Evans R Fernández Pérez; Craig E Daniels; Darrell R Schroeder; Jennifer St Sauver; Thomas E Hartman; Brian J Bartholmai; Eunhee S Yi; Jay H Ryu
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

3.  Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects.

Authors:  Sahajal Dhooria; Ritesh Agarwal; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Mandeep Garg; Amanjit Bal; Ashutosh Nath Aggarwal; Digambar Behera
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 4.  Interstitial Lung Diseases in Developing Countries.

Authors:  Pilar Rivera-Ortega; Maria Molina-Molina
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

Review 5.  Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.

Authors:  Amy Olson; Nadine Hartmann; Padmaja Patnaik; Laura Wallace; Rozsa Schlenker-Herceg; Mouhamad Nasser; Luca Richeldi; Anna-Maria Hoffmann-Vold; Vincent Cottin
Journal:  Adv Ther       Date:  2020-12-14       Impact factor: 3.845

6.  Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Authors:  Michael Kreuter; Felix J F Herth; Margarethe Wacker; Reiner Leidl; Andreas Hellmann; Michael Pfeifer; Jürgen Behr; Sabine Witt; Dagmar Kauschka; Marcus Mall; Andreas Günther; Philipp Markart
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.